Effects of hormone replacement therapy on platelet activation in postmenopausal women

Chinese Medical Journal

Volumn 116, Issue 8, 2003, Pages 1134-1136

  Gu, Jian ^a   Yang, Dongzi ^a   Wang, Liang'an ^a   Yin, Songmei ^a   Kuang, Jianquan ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hormone replacement therapy; Menopause; Platelet activation

Indexed keywords

CHOLESTEROL; CONJUGATED ESTROGEN; ESTROGEN; FIBRINOGEN RECEPTOR; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; PADGEM PROTEIN; TRIACYLGLYCEROL;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HORMONE SUBSTITUTION; HUMAN; MEDICAL ASSESSMENT; MENOPAUSAL SYNDROME; POSTMENOPAUSE; PREMENOPAUSE; STATISTICAL ANALYSIS; THROMBOCYTE ACTIVATION; TREATMENT OUTCOME;

ADULT; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PLATELET ACTIVATION; POSTMENOPAUSE;

EID: 0042330082     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Anderson HV. Estrogen therapy, atherosclerosis, and clinical cardiovascular events. Circulation 1996;94:1809-1811.
2. Skafar DF, Rui Xu, Juan Morales, et al. Female's sex hormones and cardiovascular disease in women. J Clin Endocrinal Metab 1997;82:2913-2918.
3. Dalv E, Vessey MP, Hawkin MM, et al. Risk of venous thrombolism in user of hormone replacement therapy. Lancet 1996;348:977-980.
4. Grodstein F, Stampher MJ, Goldhaber SZ, et al. Prostpective study of exogenous hormone and risk of pulmonary embolism in women. Lancet 1996;348:983-987.
5. Vorchheimer DA, BaDimon JJ, Fuster V. Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease. JAMA 1999;281:1407-1414.
6. Bernd J, Jorg H, Stylianos K, et al. Effects of estradiol on circulating P-selectin. J Clin Endocrinal Metab 1996; 81: 2351-2355.
7. Inqrid I, Surya N, Janwillem N, et al. The influence of lipoproteins on blood platelet. Am Heart J 1993 ; 125: 272-276.
8. Tikkanen MJ, Nikkila EA, Vartiainen E. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women. Lancet 1978; 2:490-491.
9. Craig H. The biology of estrogen-mediated repair of cardiovascular injry. Ann Thorac Surg 1998;65:868-874.
10. Mikkola T. 17β-Estradiol stimulates prostacyclin, but not endothelin-1 , production in human vascular endothelial cells. J Clin Endocrinol Metab 1995;80:1832-1836.
11. Sheweiki D. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91 :2235-2243.
12. Spyridopoulos I, Sullivan A, Kearney M, et al. Estrogen-receptor mediated inhibition of human endothelial cell apoptosis-estradiol as a survival factor. Circulation 1997;85: 1505-1514.
13. Heidi D, Linda L, Peggy N, et al. Post menopausal hormone replacement theray. JAMA 2002;288:488-495.